LAVA Therapeutics Stock (NASDAQ:LVTX), Quotes and News Summary

Q: What sector and industry does LAVA Therapeutics (LVTX) operate in?

LAVA Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

LAVA Therapeutics Stock (NASDAQ: LVTX) stock price, news, charts, stock research, profile.

Open	$2.940
Close	$2.830
Volume / Avg.	103.713K / 1.792M
Day Range	2.814 - 3.020
52 Wk Range	1.131 - 6.470
Market Cap	$78.867M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	48
Short Interest	1.32%
Days to Cover	1

Recent News

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet (Donald Trump Has Re-Entered The Chat)

The Benzinga Stock Whisper Index provides a look at five stocks that saw increased attention from traders over the past week.

Chris Katje

Why Humana Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Humana Inc. (NYSE: HUM) fell sharply during Thursday’s session after the company reported fourth-quarter FY23 earnings and issued 2024 guidance.

Avi Kapoor

Crude Oil Rises 2%; Tesla Shares Plunge After Downbeat Results

U.S. stocks traded slightly higher midway through trading, with the Nasdaq Composite gaining around 0.2% on Thursday. The Dow traded up 0.06% to 37,829.32 while the NASDAQ rose 0.22% to 15,515.62. The S&P 500 also rose, gaining, 0.26% to 4,881.28.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About

Sector

Healthcare

Industry

N/A

LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by d...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy LAVA Therapeutics (LVTX) stock?

You can purchase shares of LAVA Therapeutics (NASDAQ: LVTX) through any online brokerage.

View our list of the best stock brokerages.

Who are LAVA Therapeutics's (LVTX) competitors?

There are no as such competitors for LAVA Therapeutics.

What is the target price for LAVA Therapeutics (LVTX) stock?

The latest price target for LAVA Therapeutics (NASDAQ: LVTX) was reported by HC Wainwright & Co. on Thursday, March 21, 2024. The analyst firm set a price target for 6.00 expecting LVTX to rise to within 12 months (a possible 100.00% upside). 7 analyst firms have reported ratings in the last year.

Current Stock Price for LAVA Therapeutics (LVTX)?

The stock price for LAVA Therapeutics (NASDAQ: LVTX) is $3 last updated Today at April 18, 2024 at 9:17 AM EDT.

Does LAVA Therapeutics (LVTX) pay a dividend?

There are no upcoming dividends for LAVA Therapeutics.

When is LAVA Therapeutics (NASDAQ:LVTX) reporting earnings?

LAVA Therapeutics’s Q1 earnings are confirmed for Thursday, June 6, 2024.

Is LAVA Therapeutics (LVTX) going to split?

There is no upcoming split for LAVA Therapeutics.

What sector and industry does LAVA Therapeutics (LVTX) operate in?

LAVA Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.